| 8/22/2016 | CV | Market Commentary: Morning Commentary: Convertibles quiet with summer slowdown in full swing; Illumina inactive
|
| 6/19/2015 | CVLM | Medivation to redeem all $167.7 million 2.625% convertibles due 2017
|
| 3/5/2015 | CV | Market Commentary: NXP Semiconductors expands; Cheniere extends gains; Horizon Pharma deal looks ‘cheap’
|
| 8/26/2014 | CV | Market Commentary: Priceline, Illumina trade in line; Medivation, Isis in focus; Prospect Capital bid lower
|
| 4/4/2014 | CV | Market Commentary: New 51job edges up from par despite lower shares; Genco shoots up on restructuring news
|
| 1/29/2014 | CV | Market Commentary: Fluidigm talk tightened; Medivation jumps on positive trial data; Illumina trades in line
|
| 10/22/2013 | CV | Market Commentary: Midday Commentary: EMC lower, in line after earnings; Medivation sees positive drug trial news
|
| 10/22/2013 | CV | Market Commentary: Crown Castle tightens talk; United Technologies, EMC lower after earnings; Medivation flat
|
| 6/17/2013 | CV | Market Commentary: Planned Extra Space reoffered, talk revised; Weyerhaeuser launches deal; Medivation eyed
|
| 4/5/2013 | CV | Market Commentary: New Colony puts in 'solid' debut; Heartware strong despite stock shock; Medivation in line
|
| 3/18/2013 | CV | Market Commentary: Medtronic convertibles trade flat; AMR steady to higher at 110 and change; Medivation dips
|
| 11/1/2012 | CV | Market Commentary: VeriSign expands on hedge, but most convertibles in line; Medivation erases early gains
|
| 7/3/2012 | CV | Market Commentary: Convertibles quiet ahead of holiday; Lincare, Theravance extend gains; U.S. Steel better
|
| 6/4/2012 | CV | Market Commentary: Convertibles see broad-based action; Dendreon down after rival's drug news; Salesforce steady
|
| 4/10/2012 | CV | Market Commentary: DFC Global prices $200 million; Prospect Capital launches; selling hits volatility names
|
| 3/26/2012 | CV | Market Commentary: Investment-grade issues dominate convertibles market; Medtronic higher; MF Global dips
|
| 3/16/2012 | CV | Market Commentary: Convertibles slightly weaker; Salix lower; Alliant Techsystems adds on hedge; DryShips up
|
| 3/15/2012 | CV | Market Commentary: Medivation treads water; Salix comes in on hedge since issue; Clearwire flat; Southwest adds
|
| 3/14/2012 | CV | New Issue: Medivation sells upsized $225 million five-year convertibles at 2.625%, up 43.5%
|
| 3/14/2012 | CV | Market Commentary: New Medivation, Wintrust edge higher; secondary quiet; overseas new issue market heats up
|
| 3/13/2012 | CV | Price talk on Medivation's $175 million of convertibles revised to 2.625%-3.125%, up 42.5%-45%
|
| 3/13/2012 | CV | Market Commentary: New Salix pops, then retreats on debut; Medivation talk revised; Wintrust notes to price
|
| 3/12/2012 | CV | Medivation to price $175 million five-year convertibles at 2.625%-3.125%, up 37.5%-42.5%
|
| 3/12/2012 | CV | Market Commentary: Salix Pharmaceuticals, Medivation to price; Suntech Power slips; Central European extends gains
|
| 3/12/2012 | CVHYPF | Medivation files automatic shelf covering debt, stock and preferreds
|
| 8/3/2007 | CV | Medivation files automatic shelf registration
|
